Skip to content
OpenCapital
Get started

Prestige Consumer Healthcare PBH Women's Health — Total revenues

Other product segments

Gastrointestinal
$68.35M-0.8%
Eye & Ear Care
$37.85M-19.0%
Dermatologicals
$30.49M+4.8%
Analgesics
$28.24M-6.5%
Oral Care
$28M+3.3%
Cough & Cold
$26.29M-2.3%
Other OTC
$5.35M+39.2%

Similar metrics at other companies

Ziff Davis logo
ZDHealth & Wellness — Total revenues
$85.95M+0.2%
Concentra Group Holdings Parent logo
CONConsumer health — Revenue
$7.83M-9.1%
Clorox logo
CLXHealth and Wellness — Net Sales
$629M-0.2%
Kimberly-Clark logo
KMBFeminine Care — Net Sales
$451M+1.8%
Macy's logo
MWomen's Apparel — Net Sales
$1.14B+4.1%
Leidos Holdings logo
LDOSHealth — Revenue
$1.19B0.0%

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S2×-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's women's health — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's women's health — total revenues?
Prestige Consumer Healthcare (PBH) reported women's health — total revenues of $57.05M in Q1 2026.
How has Prestige Consumer Healthcare's women's health — total revenues changed year-over-year?
Prestige Consumer Healthcare's women's health — total revenues decreased by 10.6% year-over-year, from $63.78M to $57.05M.
What is the long-term trend for Prestige Consumer Healthcare's women's health — total revenues?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's women's health — total revenues has grown at a -3.7% compound annual growth rate (CAGR), from $264.51M to $227.77M.
What does women's health — total revenues mean?
This metric represents the total gross revenue generated from the sale of products within the company's dedicated women's health portfolio. It captures the market demand and commercial performance of brands focused on feminine hygiene and related personal care categories. Tracking this revenue stream provides insight into the segment's contribution to overall corporate growth and its ability to maintain category leadership in specialized consumer health markets.